Insider · CIK 0001861040
Julie Turpin
Files at BRO (BROWN & BROWN, INC.). First filing Jun 7, 2024, latest Jun 7, 2024.
In brief
Julie Turpin files SEC Form 4 as officer at BRO (BROWN & BROWN, INC.). Since Jun 7, 2024, Julie Turpin has reported 0 open-market buys worth $0 and 1 open-market sell worth $301k, the latest filed on Jun 7, 2024.
A track record needs three past buys with six months of prices behind them; Julie Turpin has 0, so none is measured yet.
The newest scored trade: sold $301k of BRO on Jun 7, 2024, filed Jun 7, 2024, scored 34 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BRO: BROWN & BROWN, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 34Weak | BROsell BROWN & BROWN, INC. | $301k 3,350 shares | -12% | +42% from low-1% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 7, 2024 | BRO BROWN & BROWN, INC. | 3,350 0.00% of outstanding | $301k | Jun 7, 2024 | none |
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | BRO BROWN & BROWN, INC. | AGrant or award Common Stock, $.10 par value (2019 SIP) | +11,704 | $0.00 | $0 | 38,973 | Mar 2, 2026 |
| Feb 26, 2026 | BRO BROWN & BROWN, INC. | AGrant or award Common Stock, $.10 par value (2019 SIP) | +2,855 | $0.00 | $0 | 41,828 | Mar 2, 2026 |
| Feb 23, 2026 | BRO BROWN & BROWN, INC. | FTax withholding Common Stock, $.10 par value | -4,418 | $69.59 | $307k | 41,036 | Feb 25, 2026 |
| May 5, 2025 | BRO BROWN & BROWN, INC. | FTax withholding Common Stock, $.10 par value | -2,226 | $110.57 | $246k | 30,320 | May 5, 2025 |
| Feb 21, 2025 | BRO BROWN & BROWN, INC. | FTax withholding Common Stock, $.10 par value | -1,392 | $111.65 | $155k | 26,890 | Feb 24, 2025 |
| Feb 24, 2025 | BRO BROWN & BROWN, INC. | AGrant or award Common Stock, $.10 par value (2019 SIP) | +6,802 | $0.00 | $0 | 46,469 | Feb 24, 2025 |
| Feb 24, 2025 | BRO BROWN & BROWN, INC. | AGrant or award Common Stock, $.10 par value (2019 SIP) | +1,342 | $0.00 | $0 | 47,811 | Feb 24, 2025 |
| Jun 7, 2024 | BRO BROWN & BROWN, INC. | SOpen-market sale Common Stock, $.10 par value | -3,350 | $89.92 | $301k | 23,597 | Jun 7, 2024 |
| Feb 25, 2024 | BRO BROWN & BROWN, INC. | FTax withholding Common Stock, $.10 par value | -2,071 | $84.24 | $174k | 26,947 | Feb 27, 2024 |
| Feb 19, 2024 | BRO BROWN & BROWN, INC. | AGrant or award Common Stock, $.10 par value (2019 SIP) | +8,120 | $0.00 | $0 | 42,181 | Feb 20, 2024 |
| Feb 19, 2024 | BRO BROWN & BROWN, INC. | AGrant or award Common Stock, $.10 par value (2019 SIP) | +1,814 | $0.00 | $0 | 43,995 | Feb 20, 2024 |
Questions about Julie Turpin
Answered from the filings on this page, as of the latest one.
Is Julie Turpin buying or selling?
Not in the last 12 months. Julie Turpin's latest open-market trade on SEC Form 4 was sold $301k of BRO on Jun 7, 2024.
How did Julie Turpin's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Julie Turpin has 0.
Where does Julie Turpin file Form 4?
Julie Turpin has filed Form 4 at BRO (BROWN & BROWN, INC.) as EVP/Chief People Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.